{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T14:13:54Z","timestamp":1789827234317,"version":"4.0.1"},"reference-count":240,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.autrev.2024.103610","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T01:34:17Z","timestamp":1724808857000},"page":"103610","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Auto-immuno-deficiency syndromes"],"prefix":"10.1016","volume":"23","author":[{"given":"Gunnar","family":"Houen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2024.103610_bb0005","series-title":"Janeway\u2019s Immunobiology","author":"Murphy","year":"2017"},{"issue":"4","key":"10.1016\/j.autrev.2024.103610_bb0010","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/joim.12395","article-title":"Human autoimmune diseases: a comprehensive update","volume":"278","author":"Wang","year":"2015","journal-title":"J Intern Med"},{"issue":"1","key":"10.1016\/j.autrev.2024.103610_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2008.03834.x","article-title":"The role of infections in autoimmune disease","volume":"155","author":"Ercolini","year":"2009","journal-title":"Clin Exp Immunol"},{"issue":"27","key":"10.1016\/j.autrev.2024.103610_bb0020","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.2174\/1381612825666190709205421","article-title":"Update on autoimmune diseases pathogenesis","volume":"25","author":"Kechida","year":"2019","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.autrev.2024.103610_bb0025","doi-asserted-by":"crossref","DOI":"10.1017\/erm.2014.5","article-title":"Gene-environment interaction in autoimmune disease","volume":"16","author":"Ellis","year":"2014","journal-title":"Expert Rev Mol Med"},{"issue":"7","key":"10.1016\/j.autrev.2024.103610_bb0030","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm.3897","article-title":"Heterogeneity of autoimmune diseases: pathophysiologic insights from genetics and implications for new therapies","volume":"21","author":"Cho","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2024.103610_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2015.08.015","article-title":"The genetics of human autoimmune disease: a perspective on progress in the field and future directions","volume":"64","author":"Seldin","year":"2015","journal-title":"J Autoimmun"},{"issue":"5","key":"10.1016\/j.autrev.2024.103610_bb0040","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-3083.2010.02386.x","article-title":"Primary immunodeficiency and autoimmunity: lessons from human diseases","volume":"71","author":"Arason","year":"2010","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.autrev.2024.103610_bb0045","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fimmu.2015.00185","article-title":"Early-onset autoimmune disease as a manifestation of primary immunodeficiency","volume":"6","author":"Carneiro-Sampaio","year":"2015","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.autrev.2024.103610_bb0050","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1007\/s00296-012-2451-z","article-title":"Infection and autoimmune disease","volume":"32","author":"Sener","year":"2012","journal-title":"Rheumatol Int"},{"issue":"3","key":"10.1016\/j.autrev.2024.103610_bb0055","doi-asserted-by":"crossref","DOI":"10.1530\/EC-21-0554","article-title":"Autoimmune disease and interconnections with vitamin D","volume":"11","author":"Fletcher","year":"2022","journal-title":"Endocr Connect"},{"key":"10.1016\/j.autrev.2024.103610_bb0060","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.1","article-title":"Rheumatoid arthritis","volume":"4","author":"Smolen","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"10.1016\/j.autrev.2024.103610_bb0065","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJMra2103726","article-title":"Rheumatoid arthritis - common origins, divergent mechanisms","volume":"388","author":"Gravallese","year":"2023","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.autrev.2024.103610_bb0070","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/j.immuni.2022.11.009","article-title":"The pathogenesis of rheumatoid arthritis","volume":"55","author":"Alivernini","year":"2022","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.autrev.2024.103610_bb0075","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3899\/jrheum.200367","article-title":"The prevalence of rheumatoid arthritis: a systematic review of population-based studies","volume":"48","author":"Almutairi","year":"2021","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2024.103610_bb0080","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00296-020-04731-0","article-title":"The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review","volume":"41","author":"Almutairi","year":"2021","journal-title":"Rheumatol Int"},{"issue":"10","key":"10.1016\/j.autrev.2024.103610_bb0085","first-page":"591","article-title":"Global epidemiology of rheumatoid arthritis","volume":"18","author":"Finckh","year":"2022","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2024.103610_bb0090","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3390\/ijms22020686","article-title":"From rheumatoid factor to anti-citrullinated protein antibodies and anti-carbamylated protein antibodies for diagnosis and prognosis prediction in patients with rheumatoid arthritis","volume":"22","author":"Wu","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.autrev.2024.103610_bb0095","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1080\/14737159.2023.2247986","article-title":"Anti-citrullinated protein antibodies as biomarkers in rheumatoid arthritis","volume":"23","author":"Trier","year":"2023","journal-title":"Expert Rev Mol Diagn"},{"issue":"9","key":"10.1016\/j.autrev.2024.103610_bb0100","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European league against rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"15","key":"10.1016\/j.autrev.2024.103610_bb0105","doi-asserted-by":"crossref","first-page":"8140","DOI":"10.3390\/ijms23158140","article-title":"Interplay of environmental, individual and genetic factors in rheumatoid arthritis provocation","volume":"23","author":"Arleevskaya","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.autrev.2024.103610_bb0110","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00281-022-00912-0","article-title":"Genetics of rheumatoid arthritis","volume":"44","author":"Padyukov","year":"2022","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.autrev.2024.103610_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.587380","article-title":"Epstein-Barr virus and systemic autoimmune diseases","volume":"11","author":"Houen","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2024.103610_bb0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s41927-023-00325-y","article-title":"Vitamin D status and risk of rheumatoid arthritis: systematic review and meta-analysis","volume":"7","author":"Clasen","year":"2023","journal-title":"BMC Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2024.103610_bb0125","first-page":"94","article-title":"Vitamin D deficiency and rheumatoid arthritis: epidemiological, immunological, clinical and therapeutic aspects","volume":"30","author":"Heidari","year":"2019","journal-title":"Mediterr J Rheumatol"},{"key":"10.1016\/j.autrev.2024.103610_bb0130","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/978-3-319-56017-5_13","article-title":"Role of vitamin D in rheumatoid arthritis","volume":"996","author":"Bellan","year":"2017","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"10.1016\/j.autrev.2024.103610_bb0135","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s12223-023-01036-0","article-title":"Immune dysregulation and pathogenic pathways mediated by common infections in rheumatoid arthritis","volume":"68","author":"Salehi","year":"2023","journal-title":"Folia Microbiol (Praha)"},{"issue":"1","key":"10.1016\/j.autrev.2024.103610_bb0140","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/rheumatology\/kes305","article-title":"The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment","volume":"52","author":"Listing","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.autrev.2024.103610_bb0145","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s12016-019-08742-z","article-title":"Toll-like receptors, infections, and rheumatoid arthritis","volume":"58","author":"Arleevskaya","year":"2020","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2024.103610_bb0150","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4103\/jrms.JRMS_567_20","article-title":"Association of the genetic polymorphisms in inhibiting and activating molecules of immune system with rheumatoid arthritis: a systematic review and meta-analysis","volume":"26","author":"Mousavi","year":"2021","journal-title":"J Res Med Sci"},{"key":"10.1016\/j.autrev.2024.103610_bb0155","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.47","article-title":"Sj\u00f6gren syndrome","volume":"2","author":"Brito-Zer\u00f3n","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"35","key":"10.1016\/j.autrev.2024.103610_bb0160","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.2174\/1381612824666181016154033","article-title":"From molecular mechanism to the etiology of Sjogren syndrome","volume":"24","author":"Wei","year":"2018","journal-title":"Curr Pharm Des"},{"issue":"3","key":"10.1016\/j.autrev.2024.103610_bb0165","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrrheum.2018.1","article-title":"B cells in the pathogenesis of primary Sj\u00f6gren syndrome","volume":"14","author":"Nocturne","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2024.103610_bb0170","first-page":"247","article-title":"The epidemiology of Sj\u00f6gren\u2019s syndrome","volume":"6","author":"Patel","year":"2014","journal-title":"Clin Epidemiol"},{"issue":"11","key":"10.1016\/j.autrev.2024.103610_bb0175","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1136\/annrheumdis-2014-205375","article-title":"Epidemiology of primary Sj\u00f6gren\u2019s syndrome: a systematic review and meta-analysis","volume":"74","author":"Qin","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103610_bb0180","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.clim.2017.04.018","article-title":"Genetics of Sj\u00f6gren\u2019s syndrome","volume":"182","author":"Teos","year":"2017","journal-title":"Clin Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2024.103610_bb0185","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.rdc.2016.03.003","article-title":"Genetics in Sj\u00f6gren syndrome","volume":"42","author":"Reksten","year":"2016","journal-title":"Rheum Dis Clin N Am"},{"issue":"6","key":"10.1016\/j.autrev.2024.103610_bb0190","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.autrev.2017.04.004","article-title":"Vitamin D and Sj\u00f6gren syndrome","volume":"16","author":"Garcia-Carrasco","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2024.103610_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.823659","article-title":"The role of virus infections in Sj\u00f6gren\u2019s syndrome","volume":"13","author":"Maslinska","year":"2022","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.autrev.2024.103610_bb0200","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.3390\/v14071474","article-title":"Virus infections play crucial roles in the pathogenesis of Sj\u00f6gren\u2019s syndrome","volume":"14","author":"Otsuka","year":"2022","journal-title":"Viruses"},{"issue":"12","key":"10.1016\/j.autrev.2024.103610_bb0205","first-page":"2387","article-title":"Candidate autoantibodies for primary Sj\u00f6gren\u2019s syndrome: where are they now?","volume":"40","author":"He","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2024.103610_bb0210","article-title":"Autoantibodies in Sj\u00f6gren\u2019s syndrome and its classification criteria","volume":"5","author":"Veenbergen","year":"2021","journal-title":"J Transl Autoimmun"},{"issue":"2","key":"10.1016\/j.autrev.2024.103610_bb0215","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.autrev.2018.09.003","article-title":"Novel autoantibodies in Sj\u00f6gren\u2019s syndrome: a comprehensive review","volume":"18","author":"Mart\u00edn-Nares","year":"2019","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.autrev.2024.103610_bb0220","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00296-020-04782-3","article-title":"IgA immunoglobulin isotype of rheumatoid factor in primary Sj\u00f6gren\u2019s syndrome","volume":"41","author":"Ma\u015bli\u0144ska","year":"2021","journal-title":"Rheumatol Int"},{"issue":"3","key":"10.1016\/j.autrev.2024.103610_bb0225","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s00784-018-2545-4","article-title":"Clinical and diagnostic significance of serum immunoglobulin a rheumatoid factor in primary Sjogren\u2019s syndrome","volume":"23","author":"Lee","year":"2019","journal-title":"Clin Oral Investig"},{"issue":"7","key":"10.1016\/j.autrev.2024.103610_bb0230","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.3390\/v14071474","article-title":"Virus infections play crucial roles in the pathogenesis of Sj\u00f6gren\u2019s syndrome","volume":"14","author":"Otsuka","year":"2022","journal-title":"Viruses"},{"issue":"13","key":"10.1016\/j.autrev.2024.103610_bb0235","article-title":"The role of virus infections in Sj\u00f6gren's syndrome","volume":"6","author":"Maslinska","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2024.103610_bb0240","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1080\/07853890.2022.2126517","article-title":"Hospitalizations for infections in primary Sj\u00f6gren\u2019s syndrome patients: a nationwide incidence study","volume":"54","author":"Goulabchand","year":"2022","journal-title":"Ann Med"},{"issue":"11","key":"10.1016\/j.autrev.2024.103610_bb0245","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/art.42270","article-title":"Strong Association of Combined Genetic Deficiencies in the classical complement pathway with risk of systemic lupus erythematosus and primary Sj\u00f6gren\u2019s syndrome","volume":"74","author":"Lundtoft","year":"2022","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2024.103610_bb0250","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.703780","article-title":"Shared pathogenetic features between common variable immunodeficiency and Sj\u00f6gren\u2019s syndrome: clues for a personalized medicine","volume":"12","author":"Quartuccio","year":"2021","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2024.103610_bb0255","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1093\/rheumatology\/keaa105","article-title":"Lymphopenia in primary Sj\u00f6gren\u2019s syndrome is associated with premature aging of na\u00efve CD4+ T cells","volume":"60","author":"Fessler","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.autrev.2024.103610_bb0260","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00296-012-2464-7","article-title":"Primary Sj\u00f6gren\u2019s syndrome and B-non-Hodgkin lymphoma: role of CD4+ T lymphocytopenia","volume":"33","author":"Ismail","year":"2013","journal-title":"Rheumatol Int"},{"issue":"4","key":"10.1016\/j.autrev.2024.103610_bb0265","first-page":"726","article-title":"CD4+ T-lymphocytopenia--a frequent finding in anti-SSA antibody seropositive patients with primary Sj\u00f6gren\u2019s syndrome","volume":"31","author":"Mandl","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2024.103610_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2018.11.001","article-title":"Systemic lupus erythematosus: diagnosis and clinical management","volume":"96","author":"Fava","year":"2019","journal-title":"J Autoimmun"},{"issue":"7","key":"10.1016\/j.autrev.2024.103610_bb0275","doi-asserted-by":"crossref","first-page":"6578","DOI":"10.3390\/ijms24076578","article-title":"Advances in the pathogenesis and treatment of systemic lupus erythematosus","volume":"24","author":"Accapezzato","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.1016\/j.autrev.2024.103610_bb0280","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European league against rheumatism\/American College of Rheumatology Classification Criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.autrev.2024.103610_bb0285","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41584-021-00668-1","article-title":"Global epidemiology of systemic lupus erythematosus","volume":"17","author":"Barber","year":"2021","journal-title":"Nat Rev Rheumatol"},{"issue":"11","key":"10.1016\/j.autrev.2024.103610_bb0290","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1093\/rheumatology\/kex260","article-title":"The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies","volume":"56","author":"Rees","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2024.103610_bb0295","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jaut.2015.08.004","article-title":"Immunogenetics of systemic lupus erythematosus: a comprehensive review","volume":"64","author":"Ghodke-Puranik","year":"2015","journal-title":"J Autoimmun"},{"issue":"10","key":"10.1016\/j.autrev.2024.103610_bb0300","article-title":"An overview of systemic lupus erythematosus (SLE) pathogenesis, classification, and management","volume":"14","author":"Ameer","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.autrev.2024.103610_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102356","article-title":"Evolving story of autoantibodies in systemic lupus erythematosus","volume":"110","author":"Pisetsky","year":"2020","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1016\/j.autrev.2024.103610_bb0310","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.autrev.2014.10.003","article-title":"A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients","volume":"14","author":"Yaniv","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"10","key":"10.1016\/j.autrev.2024.103610_bb0315","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.3390\/cells8101180","article-title":"Update on the genetics of systemic lupus erythematosus: genome-wide association studies and beyond","volume":"8","author":"Kwon","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.autrev.2024.103610_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2022.101653","article-title":"Cellular and molecular heterogeneity in systemic lupus erythematosus","volume":"58","author":"Fava","year":"2021","journal-title":"Semin Immunol"},{"key":"10.1016\/j.autrev.2024.103610_bb0325","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1146\/annurev-immunol-101921-042422","article-title":"Systemic lupus erythematosus pathogenesis: interferon and beyond","volume":"41","author":"Caielli","year":"2023","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2024.103610_bb0330","article-title":"Life factors acting on systemic lupus erythematosus","volume":"13","author":"Chen","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103610_bb0335","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/370516","article-title":"Epstein-Barr virus and systemic lupus erythematosus","volume":"2012","author":"Draborg","year":"2012","journal-title":"Clin Dev Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2024.103610_bb0340","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3390\/v13020277","article-title":"Viral infections and systemic lupus erythematosus: new players in an old story","volume":"13","author":"Quaglia","year":"2021","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.autrev.2024.103610_bb0345","doi-asserted-by":"crossref","first-page":"154","DOI":"10.4081\/reumatismo.2020.1303","article-title":"Systemic lupus erythematosus and infections","volume":"72","author":"Singh","year":"2020","journal-title":"Reumatismo"},{"issue":"1","key":"10.1016\/j.autrev.2024.103610_bb0350","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/rheumatology\/keaa478","article-title":"The risk of infections in adult patients with systemic lupus erythematosus: systematic review and meta-analysis","volume":"60","author":"Pego-Reigosa","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.autrev.2024.103610_bb0355","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s10096-014-2098-7","article-title":"Infections and systemic lupus erythematosus","volume":"33","author":"Esposito","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"10.1016\/j.autrev.2024.103610_bb0360","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2478\/rir-2021-0019","article-title":"Systemic lupus erythematosus and immunodeficiency","volume":"2","author":"Chan","year":"2021","journal-title":"Rheumatol Immunol Res"},{"issue":"1","key":"10.1016\/j.autrev.2024.103610_bb0365","doi-asserted-by":"crossref","first-page":"e245","DOI":"10.1097\/RHU.0000000000001709","article-title":"Systemic lupus erythematosus and common variable immunodeficiency","volume":"28","author":"Azar","year":"2022","journal-title":"J Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2024.103610_bb0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/25785826.2019.1628466","article-title":"Systemic lupus erythematosus and immunodeficiency","volume":"42","author":"Sawada","year":"2019","journal-title":"Immunol Med"},{"issue":"6","key":"10.1016\/j.autrev.2024.103610_bb0375","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/bjd.15607","article-title":"The pathogenesis of dermatomyositis","volume":"179","author":"Thompson","year":"2018","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.autrev.2024.103610_bb0380","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jaad.2019.06.1309","article-title":"Dermatomyositis: clinical features and pathogenesis","volume":"82","author":"DeWane","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2024.103610_bb0385","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000131751","article-title":"Dermatomyositis","volume":"10","author":"Krathen","year":"2008","journal-title":"Curr Dir Autoimmun"},{"issue":"8","key":"10.1016\/j.autrev.2024.103610_bb0390","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1136\/annrheumdis-2013-205127","article-title":"Prevalence and clinical characteristics of adult polymyositis and dermatomyositis; data from a large and unselected Norwegian cohort","volume":"74","author":"Dobloug","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2024.103610_bb0395","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/ard.60.2.116","article-title":"Autoantibody profiles in the sera of European patients with myositis","volume":"60","author":"Brouwer","year":"2001","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.autrev.2024.103610_bb0400","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.3390\/jcm10081725","article-title":"Clinical features and cutaneous manifestations of juvenile and adult patients of dermatomyositis associated with myositis-specific autoantibodies","volume":"10","author":"Okiyama","year":"2021","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.autrev.2024.103610_bb0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2478\/rir-2022-0001","article-title":"Myositis-specific antibodies: overview and clinical utilization","volume":"3","author":"Halilu","year":"2022","journal-title":"Rheumatol Immunol Res"},{"issue":"3","key":"10.1016\/j.autrev.2024.103610_bb0410","article-title":"The role of myositis-specific autoantibodies in the dermatomyositis spectrum","volume":"14","author":"Marasandra Ramesh","year":"2022","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.autrev.2024.103610_bb0415","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/art.42345","article-title":"Genetic influences in cancer-associated myositis","volume":"75","author":"Patasova","year":"2023","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.autrev.2024.103610_bb0420","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s12016-022-08922-4","article-title":"Autoantibody markers of increased risk of malignancy in patients with dermatomyositis","volume":"63","author":"Marz\u0119cka","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"issue":"12","key":"10.1016\/j.autrev.2024.103610_bb0425","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1002\/art.38137","article-title":"Genome-wide association study of dermatomyositis reveals genetic overlap with other autoimmune disorders","volume":"65","author":"Miller","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.autrev.2024.103610_bb0430","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/gene.2015.28","article-title":"Genome-wide association study identifies HLA 8.1 ancestral haplotype alleles as major genetic risk factors for myositis phenotypes","volume":"16","author":"Miller","year":"2015","journal-title":"Genes Immun"},{"issue":"6","key":"10.1016\/j.autrev.2024.103610_bb0435","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/BOR.0000000000000652","article-title":"Genetics of idiopathic inflammatory myopathies: insights into disease pathogenesis","volume":"31","author":"Rothwell","year":"2019","journal-title":"Curr Opin Rheumatol"},{"issue":"11","key":"10.1016\/j.autrev.2024.103610_bb0440","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1002\/acr.24059","article-title":"Association of ultraviolet radiation exposure with dermatomyositis in a national myositis patient registry","volume":"72","author":"Parks","year":"2020","journal-title":"Arthritis Care Res"},{"issue":"8","key":"10.1016\/j.autrev.2024.103610_bb0445","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1093\/rheumatology\/kex162","article-title":"Environmental factors associated with disease flare in juvenile and adult dermatomyositis","volume":"56","author":"Mamyrova","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.autrev.2024.103610_bb0450","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/bjd.15607","article-title":"The pathogenesis of dermatomyositis","volume":"179","author":"Thompson","year":"2018","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.autrev.2024.103610_bb0455","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/art.21068","article-title":"History of infection before the onset of juvenile dermatomyositis: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry","volume":"53","author":"Pachman","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2024.103610_bb0460","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/08916930600622348","article-title":"Polymyositis-dermatomyositis and infections","volume":"39","author":"Zampieri","year":"2006","journal-title":"Autoimmunity"},{"issue":"9","key":"10.1016\/j.autrev.2024.103610_bb0465","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1136\/annrheumdis-2015-207762","article-title":"Gene copy-number variations (CNVs) of complement C4 and C4A deficiency in genetic risk and pathogenesis of juvenile dermatomyositis","volume":"75","author":"Lintner","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2024.103610_bb0470","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/ard-2022-222935","article-title":"Low copy numbers of complement C4 and C4A deficiency are risk factors for myositis, its subgroups and autoantibodies","volume":"82","author":"Zhou","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"23","key":"10.1016\/j.autrev.2024.103610_bb0475","first-page":"223","article-title":"Type 1 diabetes","volume":"S0140-6736","author":"Quattrin","year":"2023","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.autrev.2024.103610_bb0480","doi-asserted-by":"crossref","first-page":"ITC33","DOI":"10.7326\/AITC202203150","article-title":"Type 1 Diabetes Mellitus","volume":"175","author":"Syed","year":"2022","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.autrev.2024.103610_bb0485","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0001099","article-title":"Variation in the incidence of type 1 diabetes mellitus in children and adolescents by world region and country income group: a scoping review","volume":"2","author":"Gomber","year":"2022","journal-title":"PLOS Glob Publ Health"},{"issue":"3","key":"10.1016\/j.autrev.2024.103610_bb0490","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2174\/1573399814666180730105351","article-title":"Type 1 diabetes-related autoantibodies in different forms of diabetes","volume":"15","author":"S\u00f8rgjerd","year":"2019","journal-title":"Curr Diabetes Rev"},{"issue":"6","key":"10.1016\/j.autrev.2024.103610_bb0495","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11892-016-0738-2","article-title":"Islet Autoantibodies","volume":"16","author":"Lampasona","year":"2016","journal-title":"Curr Diab Rep"},{"issue":"8","key":"10.1016\/j.autrev.2024.103610_bb0500","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S2213-8587(22)00159-0","article-title":"Type 1 diabetes in diverse ancestries and the use of genetic risk scores","volume":"10","author":"Redondo","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1016\/j.autrev.2024.103610_bb0505","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4239\/wjd.v11.i1.13","article-title":"Current understandings of the pathogenesis of type 1 diabetes: genetics to environment","volume":"11","author":"Giwa","year":"2020","journal-title":"World J Diabetes"},{"issue":"22","key":"10.1016\/j.autrev.2024.103610_bb0510","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214434","article-title":"Vitamin D and beta cells in type 1 diabetes: a systematic review","volume":"23","author":"Yu","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.autrev.2024.103610_bb0515","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1900\/RDS.2022.18.58","article-title":"Vitamin D deficiency as a possible cause of type 1 diabetes in children and adolescents up to 15 years old: a systematic review","volume":"18","author":"Daskalopoulou","year":"2022","journal-title":"Rev Diabet Stud"},{"key":"10.1016\/j.autrev.2024.103610_bb0520","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5953562","article-title":"Progress in the relationship between vitamin D deficiency and the incidence of type 1 diabetes mellitus in children","volume":"2022","author":"He","year":"2022","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.autrev.2024.103610_bb0525","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/978-1-4614-5441-0_20","article-title":"Viral infections and diabetes","volume":"771","author":"Galleri","year":"2012","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"10.1016\/j.autrev.2024.103610_bb0530","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0891-5520(05)70153-7","article-title":"Infections in diabetes","volume":"15","author":"Calvet","year":"2001","journal-title":"Infect Dis Clin N Am"},{"issue":"1","key":"10.1016\/j.autrev.2024.103610_bb0535","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3390\/jcm8010076","article-title":"Candida sp. infections in patients with diabetes mellitus","volume":"8","author":"Rodrigues","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.autrev.2024.103610_bb0540","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.966344","article-title":"Infectious diseases associated with pediatric type 1 diabetes mellitus: a narrative review","volume":"13","author":"Piccolo","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"23","key":"10.1016\/j.autrev.2024.103610_bb0545","article-title":"Type 1 diabetes and inborn errors of immunity: complete strangers or 2 sides of the same coin?","volume":"S0091-6749","author":"Mancuso","year":"2023","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2024.103610_bb0550","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41572-020-0184-y","article-title":"Graves\u2019 disease","volume":"6","author":"Davies","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.autrev.2024.103610_bb0555","doi-asserted-by":"crossref","DOI":"10.1177\/11795514221150615","article-title":"Graves\u2019 disease in children: an update","volume":"16","author":"Metwalley","year":"2023","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"issue":"1","key":"10.1016\/j.autrev.2024.103610_bb0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2020.101387","article-title":"Graves\u2019 disease: epidemiology, genetic and environmental risk factors and viruses","volume":"34","author":"Antonelli","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.autrev.2024.103610_bb0565","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ando.2018.09.002","article-title":"Graves\u2019 disease: introduction, epidemiology, endogenous and environmental pathogenic factors","volume":"79","author":"W\u00e9meau","year":"2018","journal-title":"Ann Endocrinol (Paris)"},{"issue":"2","key":"10.1016\/j.autrev.2024.103610_bb0570","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1530\/JME-20-0078","article-title":"Graves\u2019 disease: introducing new genetic and epigenetic contributors","volume":"66","author":"Razmara","year":"2021","journal-title":"J Mol Endocrinol"},{"issue":"6","key":"10.1016\/j.autrev.2024.103610_bb0575","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1507\/endocrj.EJ22-0609","article-title":"Epstein-Barr virus reactivation in peripheral B lymphocytes induces IgM-type thyrotropin receptor autoantibody production in patients with Graves\u2019 disease","volume":"70","author":"Nagata","year":"2023","journal-title":"Endocr J"},{"issue":"13","key":"10.1016\/j.autrev.2024.103610_bb0580","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.3390\/ijms20133145","article-title":"Does the Epstein-Barr virus play a role in the pathogenesis of graves\u2019 disease?","volume":"20","author":"Pyzik","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.autrev.2024.103610_bb0585","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12916-017-0939-9","article-title":"Is Graves\u2019 disease a primary immunodeficiency? New immunological perspectives on an endocrine disease","volume":"15","author":"Struja","year":"2017","journal-title":"BMC Med"},{"issue":"3","key":"10.1016\/j.autrev.2024.103610_bb0590","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028936","article-title":"Multiple sclerosis pathology","volume":"8","author":"Lassmann","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"10130","key":"10.1016\/j.autrev.2024.103610_bb0595","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(18)30481-1","article-title":"Multiple sclerosis","volume":"391","author":"Thompson","year":"2018","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.autrev.2024.103610_bb0600","doi-asserted-by":"crossref","first-page":"8251","DOI":"10.3390\/ijms24098251","article-title":"The state of the art of pediatric multiple sclerosis","volume":"24","author":"Teleanu","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.autrev.2024.103610_bb0605","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2023.1135","article-title":"Population-based estimates for the prevalence of multiple sclerosis in the United States by race, ethnicity, age, sex, and geographic region","volume":"80","author":"Hittle","year":"2023","journal-title":"JAMA Neurol"},{"issue":"18","key":"10.1016\/j.autrev.2024.103610_bb0610","doi-asserted-by":"crossref","first-page":"e1818","DOI":"10.1212\/WNL.0000000000200151","article-title":"Racial and ethnic disparities in multiple sclerosis prevalence","volume":"98","author":"Langer-Gould","year":"2022","journal-title":"Neurology"},{"issue":"14","key":"10.1016\/j.autrev.2024.103610_bb0615","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: insights from the atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Mult Scler"},{"issue":"35","key":"10.1016\/j.autrev.2024.103610_bb0620","doi-asserted-by":"crossref","first-page":"21512","DOI":"10.1073\/pnas.2011249117","article-title":"Autoantibodies against central nervous system antigens in a subset of B cell-dominant multiple sclerosis patients","volume":"117","author":"Kuerten","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.autrev.2024.103610_bb0625","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000765","article-title":"Serum antibodies to phosphatidylcholine in MS","volume":"7","author":"S\u00e1daba","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"11","key":"10.1016\/j.autrev.2024.103610_bb0630","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41582-022-00700-2","article-title":"Pathogenic autoantibodies in multiple sclerosis - from a simple idea to a complex concept","volume":"18","author":"H\u00f6ftberger","year":"2022","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.autrev.2024.103610_bb0635","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/1352458517737371","article-title":"Multiple sclerosis genetics","volume":"24","author":"Canto","year":"2018","journal-title":"Mult Scler"},{"issue":"9","key":"10.1016\/j.autrev.2024.103610_bb0640","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S1474-4422(22)00255-1","article-title":"Genetics of multiple sclerosis: lessons from polygenicity","volume":"21","author":"Goris","year":"2022","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.autrev.2024.103610_bb0645","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246157","article-title":"The nature of genetic and environmental susceptibility to multiple sclerosis","volume":"16","author":"Goodin","year":"2021","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.autrev.2024.103610_bb0650","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/1352458519872664","article-title":"Environmental factors and risk of multiple sclerosis: findings from meta-analyses and Mendelian randomization studies","volume":"26","author":"Belbasis","year":"2020","journal-title":"Mult Scler"},{"issue":"2","key":"10.1016\/j.autrev.2024.103610_bb0655","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3390\/ijms20020303","article-title":"The interaction between viral and environmental risk factors in the pathogenesis of multiple sclerosis","volume":"20","author":"Tarlinton","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"6578","key":"10.1016\/j.autrev.2024.103610_bb0660","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.autrev.2024.103610_bb0665","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.587078","article-title":"Epstein-Barr virus and multiple sclerosis","volume":"11","author":"Houen","year":"2020","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.autrev.2024.103610_bb0670","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1080\/1744666X.2021.1847642","article-title":"The role of Epstein-Barr virus in the etiology of multiple sclerosis: a current review","volume":"16","author":"Ruprecht","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2024.103610_bb0675","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcad065","article-title":"Infections among individuals with multiple sclerosis, Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"5","author":"Hu","year":"2023","journal-title":"Brain Commun"},{"issue":"3","key":"10.1016\/j.autrev.2024.103610_bb0680","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.3390\/jcm12031023","article-title":"Clinically manifest infections do not increase the relapse risk in people with multiple sclerosis treated with disease-modifying therapies: a prospective study","volume":"12","author":"Miele","year":"2023","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.autrev.2024.103610_bb0685","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/1352458520952311","article-title":"The risk of infection in patients with multiple sclerosis treated with disease-modifying therapies: a Delphi consensus statement","volume":"27","author":"Moiola","year":"2021","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2024.103610_bb0690","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1133444","article-title":"Ratio of lymphocyte to monocyte area under the curve as a novel predictive factor for severe infection in multiple sclerosis","volume":"14","author":"Takahashi","year":"2023","journal-title":"Front Immunol"},{"issue":"14","key":"10.1016\/j.autrev.2024.103610_bb0695","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1177\/1352458514536252","article-title":"Deficiency of CD8+ effector memory T cells is an early and persistent feature of multiple sclerosis","volume":"20","author":"Pender","year":"2014","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2024.103610_bb0700","article-title":"Association between rheumatoid arthritis and thyroid dysfunction: a meta-analysis and systematic review","volume":"13","author":"Liu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"10.1016\/j.autrev.2024.103610_bb0705","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.semarthrit.2006.08.007","article-title":"The overlap of Sj\u00f6gren\u2019s syndrome with other systemic autoimmune diseases","volume":"36","author":"Ramos-Casals","year":"2007","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2024.103610_bb0710","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.rdc.2016.03.005","article-title":"Polyautoimmunity in Sj\u00f6gren syndrome","volume":"42","author":"Anaya","year":"2016","journal-title":"Rheum Dis Clin N Am"},{"key":"10.1016\/j.autrev.2024.103610_bb0715","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fendo.2018.00121","article-title":"The Association of Sj\u00f6gren Syndrome and Autoimmune Thyroid Disorders","volume":"9","author":"Baldini","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.autrev.2024.103610_bb0720","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2147\/OARRR.S167783","article-title":"Sj\u00f6gren's syndrome and systemic lupus erythematosus: links and risks","volume":"11","author":"Pasoto","year":"2019","journal-title":"Open Access Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2024.103610_bb0725","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1136\/ard.2006.055103","article-title":"Autoimmune thyroid disease is associated with a diagnosis of secondary Sj\u00f6gren\u2019s syndrome in familial systemic lupus","volume":"66","author":"Scofield","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2024.103610_bb0730","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0049-0172(05)80004-6","article-title":"The coexistence of systemic lupus erythematosus with other autoimmune diseases: the kaleidoscope of autoimmunity","volume":"24","author":"Lorber","year":"1994","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2024.103610_bb0735","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000635","article-title":"Clinical and histopathological features of myositis in systemic lupus erythematosus","volume":"9","author":"Tiniakou","year":"2022","journal-title":"Lupus Sci Med"},{"issue":"7","key":"10.1016\/j.autrev.2024.103610_bb0740","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1177\/0961203320918021","article-title":"Inflammatory myositis in systemic lupus erythematosus","volume":"29","author":"Bitencourt","year":"2020","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.autrev.2024.103610_bb0745","first-page":"438","article-title":"Hematologic manifestations of primary Sj\u00f6gren\u2019s syndrome","volume":"24","author":"Manganelli","year":"2006","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2024.103610_bb0750","first-page":"140","article-title":"Hematologic manifestations of connective autoimmune diseases","volume":"27","author":"Fietta","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2024.103610_bb0755","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1083690","article-title":"Graves\u2019 disease is more prevalent than Hashimoto disease in children and adolescents with type 1 diabetes","volume":"13","author":"Wang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.autrev.2024.103610_bb0760","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3389\/fendo.2020.00476","article-title":"Increasing co-occurrence of additional autoimmune disorders at diabetes type 1 onset among children and adolescents diagnosed in years 2010-2018-single-center study","volume":"11","author":"G\u0142owi\u0144ska-Olszewska","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"10.1016\/j.autrev.2024.103610_bb0765","doi-asserted-by":"crossref","first-page":"344","DOI":"10.5603\/PJNNS.a2023.0038","article-title":"Multiple sclerosis and autoimmune diseases - a case control study","volume":"57","author":"Wawrzyniak","year":"2023","journal-title":"Neurol Neurochir Pol"},{"issue":"7","key":"10.1016\/j.autrev.2024.103610_bb0770","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/archneur.63.7.1001","article-title":"Type 1 diabetes and multiple sclerosis: a Danish population-based cohort study","volume":"63","author":"Nielsen","year":"2006","journal-title":"Arch Neurol"},{"issue":"1\u20132","key":"10.1016\/j.autrev.2024.103610_bb0775","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jns.2014.11.019","article-title":"The co-occurrence of multiple sclerosis and type 1 diabetes: shared aetiologic features and clinical implication for MS aetiology","volume":"348","author":"Tettey","year":"2015","journal-title":"J Neurol Sci"},{"issue":"2","key":"10.1016\/j.autrev.2024.103610_bb0780","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/XCE.0000000000000244","article-title":"The relationship between rheumatoid arthritis and diabetes mellitus: a systematic review and meta-analysis","volume":"10","author":"Tian","year":"2021","journal-title":"Cardiovasc Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.autrev.2024.103610_bb0785","first-page":"115","article-title":"Diabetes mellitus risk factors in rheumatoid arthritis: a systematic review and meta-analysis","volume":"33","author":"Jiang","year":"2015","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2024.103610_bb0790","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/art.24362","article-title":"Specific association of type 1 diabetes mellitus with anti-cyclic citrullinated peptide-positive rheumatoid arthritis","volume":"60","author":"Liao","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2024.103610_bb0795","first-page":"115","article-title":"Diabetes mellitus risk factors in rheumatoid arthritis: a systematic review and meta-analysis","volume":"33","author":"Jiang","year":"2015","journal-title":"Clin Exp Rheumatol"},{"issue":"26","key":"10.1016\/j.autrev.2024.103610_bb0800","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003999","article-title":"Increased incidence of rheumatoid arthritis in multiple sclerosis: a nationwide cohort study","volume":"95","author":"Tseng","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.autrev.2024.103610_bb0805","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1177\/1352458508088936","article-title":"Autoimmune diseases in patients with multiple sclerosis and their first-degree relatives: a nationwide cohort study in Denmark","volume":"14","author":"Nielsen","year":"2008","journal-title":"Mult Scler"},{"issue":"3","key":"10.1016\/j.autrev.2024.103610_bb0810","first-page":"159","article-title":"Multiple autoimmune syndromes","volume":"139","author":"Humbert","year":"1988","journal-title":"Ann Med Intern (Paris)"},{"issue":"2","key":"10.1016\/j.autrev.2024.103610_bb0815","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.autrev.2013.07.006","article-title":"Autoimmune polyendocrine syndromes","volume":"13","author":"Cutolo","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"12","key":"10.1016\/j.autrev.2024.103610_bb0820","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJMra1713301","article-title":"Autoimmune polyendocrine syndromes","volume":"378","author":"Husebye","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.autrev.2024.103610_bb0825","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s40618-017-0740-9","article-title":"Polyglandular autoimmune syndromes","volume":"41","author":"Kahaly","year":"2018","journal-title":"J Endocrinol Investig"},{"issue":"8","key":"10.1016\/j.autrev.2024.103610_bb0830","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103135","article-title":"Autoimmune polyendocrine syndrome type 1: clinical manifestations, pathogenetic features, and management approach","volume":"21","author":"Bj\u00f8rklund","year":"2022","journal-title":"Autoimmun Rev"},{"issue":"11","key":"10.1016\/j.autrev.2024.103610_bb0835","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1007\/s40618-021-01585-6","article-title":"Autoimmune polyendocrine syndrome type 1: an Italian survey on 158 patients","volume":"44","author":"Garelli","year":"2021","journal-title":"J Endocrinol Investig"},{"key":"10.1016\/j.autrev.2024.103610_bb0840","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.coi.2017.10.003","article-title":"Insights into immune tolerance from AIRE deficiency","volume":"49","author":"Proekt","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.autrev.2024.103610_bb0845","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3389\/fimmu.2013.00326","article-title":"The many faces of aire in central tolerance","volume":"4","author":"Laan","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103610_bb0850","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3930750","article-title":"The role of autoimmune regulator (AIRE) in peripheral tolerance","volume":"2018","author":"Zhao","year":"2018","journal-title":"J Immunol Res"},{"issue":"6","key":"10.1016\/j.autrev.2024.103610_bb0855","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s40618-014-0233-z","article-title":"Vitamin D and autoimmunity: what happens in autoimmune polyendocrine syndromes?","volume":"38","author":"Bellastella","year":"2015","journal-title":"J Endocrinol Investig"},{"issue":"3","key":"10.1016\/j.autrev.2024.103610_bb0860","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s11154-016-9405-9","article-title":"Does vitamin D play a role in autoimmune endocrine disorders? A proof of concept","volume":"18","author":"Altieri","year":"2017","journal-title":"Rev Endocr Metab Disord"},{"issue":"2","key":"10.1016\/j.autrev.2024.103610_bb0865","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/MCG.0b013e31827356e1","article-title":"Gastrointestinal manifestations in APECED syndrome","volume":"47","author":"Kluger","year":"2013","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.autrev.2024.103610_bb0870","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2021.108851","article-title":"Patients with autoimmune polyendocrine syndrome type 1 have an increased susceptibility to severe herpesvirus infections","volume":"231","author":"Hetem\u00e4ki","year":"2021","journal-title":"Clin Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2024.103610_bb0875","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.cell.2016.06.024","article-title":"AIRE-deficient patients harbor unique high-affinity disease-ameliorating autoantibodies","volume":"166","author":"Meyer","year":"2016","journal-title":"Cell"},{"issue":"2\u20133","key":"10.1016\/j.autrev.2024.103610_bb0880","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s12026-013-8418-7","article-title":"Detecting multiple autoantibodies to diagnose autoimmune co-morbidity (multiple autoimmune syndromes and overlap syndromes): a challenge for the autoimmunologist","volume":"56","author":"Tozzoli","year":"2013","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2024.103610_bb0885","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.coi.2021.05.007","article-title":"Anti-interferon-\u03b3 autoantibody-associated immunodeficiency","volume":"72","author":"Shih","year":"2021","journal-title":"Curr Opin Immunol"},{"issue":"7","key":"10.1016\/j.autrev.2024.103610_bb0890","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1177\/1535370220981579","article-title":"Minireview: insights into anti-interferon-\u03b3 autoantibodies","volume":"246","author":"Chawansuntati","year":"2021","journal-title":"Exp Biol Med (Maywood)"},{"issue":"1","key":"10.1016\/j.autrev.2024.103610_bb0895","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12879-024-09003-x","article-title":"Multiple intracellular pathogen infections with ocular pathologies associated with adult-onset immunodeficiency due to anti-interferon-\u03b3 autoantibodies: a case report","volume":"24","author":"Ning","year":"2024","journal-title":"BMC Infect Dis"},{"issue":"12","key":"10.1016\/j.autrev.2024.103610_bb0900","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/ijd.16870","article-title":"Prevalence and clinical manifestations of cutaneous findings in patients with adult-onset immunodeficiency due to anti-interferon gamma autoantibodies: an eight-year retrospective study","volume":"62","author":"Pattanaprichakul","year":"2023","journal-title":"Int J Dermatol"},{"issue":"7988","key":"10.1016\/j.autrev.2024.103610_bb0905","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/s41586-023-06717-x","article-title":"Autoantibodies against type I IFNs in humans with alternative NF-\u03baB pathway deficiency","volume":"623","author":"Le Voyer","year":"2023","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.autrev.2024.103610_bb0910","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s10096-023-04688-5","article-title":"Severe acute herpes virus type 2 primo-infection and its association with anti-type 1 interferon autoantibodies","volume":"42","author":"Martinot","year":"2023","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"10.1016\/j.autrev.2024.103610_bb0915","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20231353","article-title":"Higher COVID-19 pneumonia risk associated with anti-IFN-\u03b1 than with anti-IFN-\u03c9 auto-abs in children","volume":"221","author":"Bastard","year":"2024","journal-title":"J Exp Med"},{"issue":"9","key":"10.1016\/j.autrev.2024.103610_bb0920","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40618-020-01229-1","article-title":"Prevalence of other autoimmune diseases in polyglandular autoimmune syndromes type II and III","volume":"43","author":"Pham-Dobor","year":"2020","journal-title":"J Endocrinol Investig"},{"issue":"4","key":"10.1016\/j.autrev.2024.103610_bb0925","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s40618-022-01994-1","article-title":"Type 3 autoimmune polyglandular syndrome (APS-3) or type 3 multiple autoimmune syndrome (MAS-3): an expanding galaxy","volume":"46","author":"Betterle","year":"2023","journal-title":"J Endocrinol Investig"},{"issue":"2","key":"10.1016\/j.autrev.2024.103610_bb0930","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.autrev.2013.07.006","article-title":"Autoimmune polyendocrine syndromes","volume":"13","author":"Cutolo","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2024.103610_bb0935","first-page":"1","article-title":"Autoantibodies as diagnostic tools","volume":"2019","author":"Houen","year":"1901","journal-title":"Methods Mol Biol"},{"issue":"7","key":"10.1016\/j.autrev.2024.103610_bb0940","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1191\/0961203306lu2323oa","article-title":"Quantitation of autoantibodies in systemic autoimmune diseases: clinically useful?","volume":"15","author":"Kallenberg","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2024.103610_bb0945","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.autrev.2007.01.006","article-title":"Autoantibodies as predictors of disease: the clinical and experimental evidence","volume":"6","author":"Bizzaro","year":"2007","journal-title":"Autoimmun Rev"},{"issue":"8","key":"10.1016\/j.autrev.2024.103610_bb0950","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.autrev.2008.06.007","article-title":"Challenges to the use of autoantibodies as predictors of disease onset, diagnosis and outcomes","volume":"7","author":"Fritzler","year":"2008","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2024.103610_bb0955","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/jalm\/jfab128","article-title":"Mistaken identity: the role of autoantibodies in endocrine disease","volume":"7","author":"Nelson","year":"2022","journal-title":"J Appl Lab Med"},{"issue":"6","key":"10.1016\/j.autrev.2024.103610_bb0960","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1172\/JCI78089","article-title":"T cells in the control of organ-specific autoimmunity","volume":"125","author":"Bluestone","year":"2015","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.autrev.2024.103610_bb0965","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1189\/jlb.3RU0914-443R","article-title":"Role of gamma-delta (\u03b3\u03b4) T cells in autoimmunity","volume":"97","author":"Paul","year":"2015","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.autrev.2024.103610_bb0970","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3389\/fimmu.2013.00321","article-title":"MHC class II polymorphisms, autoreactiveT-cells, and autoimmunity","volume":"4","author":"Tsai","year":"2013","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.autrev.2024.103610_bb0975","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.autrev.2013.04.005","article-title":"Enhanced killing activity of regulatory T cells ameliorates inflammation and autoimmunity","volume":"12","author":"Askenasy","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2024.103610_bb0980","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/08916931003782155","article-title":"Natural regulatory T cells in autoimmunity","volume":"44","author":"Louren\u00e7o","year":"2011","journal-title":"Autoimmunity"},{"issue":"1","key":"10.1016\/j.autrev.2024.103610_bb0985","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/ni.1818","article-title":"Regulatory T cells exert checks and balances on self tolerance and autoimmunity","volume":"11","author":"Wing","year":"2010","journal-title":"Nat Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2024.103610_bb0990","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.coi.2005.09.014","article-title":"CD8+ T cells in autoimmunity","volume":"17","author":"Walter","year":"2005","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.autrev.2024.103610_bb0995","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.948259","article-title":"Aire and Fezf2, two regulators in medullary thymic epithelial cells, control autoimmune diseases by regulating TSAs: partner or complementer?","volume":"13","author":"Qi","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103610_bb1000","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jaut.2017.08.001","article-title":"New insights into non-conventional epitopes as T cell targets: the missing link for breaking immune tolerance in autoimmune disease?","volume":"84","author":"Harbige","year":"2017","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1016\/j.autrev.2024.103610_bb1005","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.coi.2011.12.003","article-title":"Autoantigenesis: the evolution of protein modifications in autoimmune disease","volume":"24","author":"Doyle","year":"2012","journal-title":"Curr Opin Immunol"},{"issue":"11","key":"10.1016\/j.autrev.2024.103610_bb1010","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11892-015-0668-4","article-title":"Progress in understanding type 1 diabetes through its genetic overlap with other autoimmune diseases","volume":"15","author":"Roizen","year":"2015","journal-title":"Curr Diab Rep"},{"issue":"1","key":"10.1016\/j.autrev.2024.103610_bb1015","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00281-021-00885-6","article-title":"Genetic overlap between type 1 diabetes and other autoimmune diseases","volume":"44","author":"M\u00e1rquez","year":"2022","journal-title":"Semin Immunopathol"},{"issue":"23","key":"10.1016\/j.autrev.2024.103610_bb1020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399405009981","article-title":"HLA, CTLA-4 and PTPN22\u202f: the shared genetic master-key to autoimmunity?","volume":"7","author":"Brand","year":"2005","journal-title":"Expert Rev Mol Med"},{"issue":"10","key":"10.1016\/j.autrev.2024.103610_bb1025","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/nrrheum.2014.109","article-title":"PTPN22: the archetypal non-HLA autoimmunity gene","volume":"10","author":"Stanford","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2024.103610_bb1030","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106221","article-title":"CTLA-4: from mechanism to autoimmune therapy","volume":"80","author":"Hosseini","year":"2020","journal-title":"Int Immunopharmacol"},{"issue":"12","key":"10.1016\/j.autrev.2024.103610_bb1035","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.autrev.2013.07.002","article-title":"CTLA-4 and autoimmunity: new insights into the dual regulator of tolerance","volume":"12","author":"Romo-Tena","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2024.103610_bb1040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/tan.13429","article-title":"The complexity and diversity of major histocompatibility complex challenge disease association studies","volume":"93","author":"Lokki","year":"2019","journal-title":"HLA"},{"issue":"5","key":"10.1016\/j.autrev.2024.103610_bb1045","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/iji.12332","article-title":"What has GWAS done for HLA and disease associations?","volume":"44","author":"Kennedy","year":"2017","journal-title":"Int J Immunogenet"},{"issue":"1","key":"10.1016\/j.autrev.2024.103610_bb1050","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3390\/ijms19010317","article-title":"Human MHC-II with shared epitope motifs are optimal Epstein-Barr virus glycoprotein 42 ligands-relation to rheumatoid arthritis","volume":"19","author":"Trier","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.autrev.2024.103610_bb1055","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/tan.13305","article-title":"Autoimmune diseases and 8.1 ancestral haplotype: an update","volume":"92","author":"Gambino","year":"2018","journal-title":"HLA"},{"key":"10.1016\/j.autrev.2024.103610_bb1060","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fped.2016.00107","article-title":"Unbalanced immune system: Immunodeficiencies and autoimmunity","volume":"4","author":"Giardino","year":"2016","journal-title":"Front Pediatr"},{"issue":"5","key":"10.1016\/j.autrev.2024.103610_bb1065","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jaci.2016.12.978","article-title":"Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies","volume":"140","author":"Fischer","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2024.103610_bb1070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102979","article-title":"The complement system and human autoimmune diseases","volume":"137","author":"Coss","year":"2023","journal-title":"J Autoimmun"},{"issue":"2","key":"10.1016\/j.autrev.2024.103610_bb1075","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/ene.14597","article-title":"Epstein-Barr virus infection after adolescence and human herpesvirus 6A as risk factors for multiple sclerosis","volume":"28","author":"Bistr\u00f6m","year":"2021","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.autrev.2024.103610_bb1080","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.937583","article-title":"Infectious mononucleosis is associated with an increased incidence of multiple sclerosis: results from a cohort study of 32,116 outpatients in Germany","volume":"13","author":"Loosen","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103610_bb1085","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1212676","article-title":"Risk factors for multiple sclerosis in the context of Epstein-Barr virus infection","volume":"14","author":"Hedstr\u00f6m","year":"2023","journal-title":"Front Immunol"},{"issue":"26","key":"10.1016\/j.autrev.2024.103610_bb1090","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1016\/j.cell.2023.11.015","article-title":"Ineffective control of Epstein-Barr-virus-induced autoimmunity increases the risk for multiple sclerosis","volume":"186","author":"Vietzen","year":"2023","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.autrev.2024.103610_bb1095","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1177\/1352458513509703","article-title":"HLA-E restricted CD8+ T cell subsets are phenotypically altered in multiple sclerosis patients","volume":"20","author":"Pannemans","year":"2014","journal-title":"Mult Scler"},{"issue":"4","key":"10.1016\/j.autrev.2024.103610_bb1100","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/BOR.0000000000000289","article-title":"How compelling are the data for Epstein-Barr virus being a trigger for systemic lupus and other autoimmune diseases?","volume":"28","author":"Draborg","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2024.103610_bb1105","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/535738","article-title":"Epstein-Barr virus in systemic autoimmune diseases","volume":"2013","author":"Draborg","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.autrev.2024.103610_bb1110","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/370516","article-title":"Epstein-Barr virus and systemic lupus erythematosus","volume":"2012","author":"Draborg","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.autrev.2024.103610_bb1115","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3389\/fimmu.2018.00969","article-title":"Cellular and molecular mechanisms of anti-phospholipid syndrome","volume":"9","author":"Radic","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2024.103610_bb1120","article-title":"Felty\u2019s syndrome","volume":"10","author":"Wegscheider","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.autrev.2024.103610_bb1125","doi-asserted-by":"crossref","DOI":"10.1177\/17562864231213240","article-title":"Guideline for the management of myasthenic syndromes","volume":"16","author":"Wiendl","year":"2023","journal-title":"Ther Adv Neurol Disord"},{"issue":"23","key":"10.1016\/j.autrev.2024.103610_bb1130","article-title":"Autonomic nervous system involvement in autoimmune encephalitis and paraneoplastic neurological syndromes","volume":"S0035-3787","author":"Villagr\u00e1n-Garc\u00eda","year":"2023","journal-title":"Rev Neurol (Paris)"},{"issue":"15","key":"10.1016\/j.autrev.2024.103610_bb1135","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.3390\/diagnostics13152589","article-title":"Autoimmune encephalitis with antibodies: anti-NMDAR, anti-AMPAR, anti-GQ1b, anti-DPPX, anti-CASPR2, anti-LGI1, anti-RI, anti-Yo, anti-Hu, anti-CV2 and anti-GABAAR, in the course of Psychoses, Neoplastic Diseases, and Paraneoplastic Syndromes","volume":"13","author":"Braczkowski","year":"2023","journal-title":"Diagnostics (Basel)"},{"issue":"3","key":"10.1016\/j.autrev.2024.103610_bb1140","first-page":"251","article-title":"Current strategies for the treatment of autoimmune diseases","volume":"24","author":"Rosato","year":"2010","journal-title":"J Biol Regul Homeost Agents"},{"issue":"1","key":"10.1016\/j.autrev.2024.103610_bb1145","first-page":"84","article-title":"Repeated treatment with high dose cyclophosphamide for severe autoimmune diseases","volume":"3","author":"Dezern","year":"2013","journal-title":"Am J Blood Res"},{"issue":"19\u201320","key":"10.1016\/j.autrev.2024.103610_bb1150","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.drudis.2009.07.002","article-title":"Understanding autoimmune disease: new targets for drug discovery","volume":"14","author":"Balagu\u00e9","year":"2009","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.autrev.2024.103610_bb1155","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1197364","article-title":"Immune-related adverse effects of checkpoint immunotherapy and implications for the treatment of patients with cancer and autoimmune diseases","volume":"14","author":"Ibis","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2024.103610_bb1160","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S1474-4422(23)00369-1","article-title":"Neurological adverse events of immune checkpoint inhibitors and the development of paraneoplastic neurological syndromes","volume":"23","author":"Farina","year":"2024","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2024.103610_bb1165","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2023.102283","article-title":"Immune checkpoint receptors in autoimmunity","volume":"80","author":"Burke","year":"2023","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.autrev.2024.103610_bb1170","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.883733","article-title":"Co-inhibitory molecules - their role in health and autoimmunity; highlighted by immune related adverse events front","volume":"13","author":"Greisen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.autrev.2024.103610_bb1175","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.790386","article-title":"Bridging the gap: connecting the mechanisms of immune-related adverse events and autoimmunity through PD-1","volume":"9","author":"Mor","year":"2022","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.autrev.2024.103610_bb1180","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/imr.13242","article-title":"Rheumatic complications of checkpoint inhibitors: lessons from autoimmunity","volume":"318","author":"Reynolds","year":"2023","journal-title":"Immunol Rev"},{"issue":"17","key":"10.1016\/j.autrev.2024.103610_bb1185","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713609","article-title":"Antibody cross-reactivity in auto-immune diseases","volume":"24","author":"Trier","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.autrev.2024.103610_bb1190","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s42255-022-00575-z","article-title":"Non-oxidative pentose phosphate pathway controls regulatory T cell function by integrating metabolism and epigenetics","volume":"4","author":"Liu","year":"2022","journal-title":"Nat Metab"},{"issue":"1","key":"10.1016\/j.autrev.2024.103610_bb1195","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s42255-022-00711-9","article-title":"Cytosolic aldose metabolism contributes to progression from cirrhosis to hepatocarcinogenesis","volume":"5","author":"Oaks","year":"2023","journal-title":"Nat Metab"},{"key":"10.1016\/j.autrev.2024.103610_bb1200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103112","article-title":"mTOR-dependent loss of PON1 secretion and antiphospholipid autoantibody production underlie autoimmunity-mediated cirrhosis in transaldolase deficiency","volume":"140","author":"Winans","year":"2023","journal-title":"J Autoimmun"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997224001010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997224001010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T05:03:17Z","timestamp":1726376597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997224001010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":240,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1568997224001010"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2024.103610","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Auto-immuno-deficiency syndromes","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2024.103610","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103610"}}